Skip to main content
Back to Show
PBS News Hour

What we know about remdesivir study and COVID-19 antibodies

Testing, both for active cases of COVID-19 and for antibodies indicating prior exposure to the disease, will be critical to resuming economic activity. In addition, scientists are racing to develop therapies for people who do get infected -- especially those who become seriously ill. Science correspondent Miles O’Brien joins Judy Woodruff to discuss the latest on COVID-19 testing and treatment.

Support Provided By
Season
September 26, 2024 - PBS News Hour full episode
57:46
September 26, 2024 - PBS News Hour full episode
September 25, 2024 - PBS News Hour full episode
57:46
September 25, 2024 - PBS News Hour full episode
September 24, 2024 - PBS News Hour full episode
57:46
September 24, 2024 - PBS News Hour full episode
September 23, 2024 - PBS News Hour full episode
57:46
September 23, 2024 - PBS News Hour full episode
September 22, 2024 - PBS News Weekend full episode
26:45
September 22, 2024 - PBS News Weekend full episode
September 21, 2024 - PBS News Weekend full episode
26:46
September 21, 2024 - PBS News Weekend full episode
September 20, 2024 - PBS News Hour full episode
57:46
September 20, 2024 - PBS News Hour full episode
September 19, 2024 - PBS News Hour full episode
57:46
September 19, 2024 - PBS News Hour full episode
September 18, 2024 - PBS News Hour full episode
57:46
September 18, 2024 - PBS News Hour full episode
September 17, 2024 - PBS News Hour full episode
57:46
September 17, 2024 - PBS News Hour full episode
September 16, 2024 - PBS News Hour full episode
57:46
September 16, 2024 - PBS News Hour full episode
September 15, 2024 - PBS News Weekend full episode
26:46
September 15, 2024 - PBS News Weekend full episode
Active loading indicator